These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32319540)

  • 1. Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p.
    Cao Y; Lv W; Ding W; Li J
    Int J Mol Med; 2020 Jul; 46(1):97-106. PubMed ID: 32319540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
    Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
    J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
    Sun Y; Liu L; Xing W; Sun H
    Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
    Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
    J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA‑25‑3p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN/PI3K/AKT signaling pathway.
    Zi Y; Zhang Y; Wu Y; Zhang L; Yang R; Huang Y
    Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
    Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of microRNA-206 and its target gene IGF-1 on sevoflurane-induced activation of hippocampal astrocytes in aged rats through the PI3K/AKT/CREB signaling pathway.
    Liu TJ; Wang B; Li QX; Dong XL; Han XL; Zhang SB
    J Cell Physiol; 2018 May; 233(5):4294-4306. PubMed ID: 29052839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
    Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Qiu DZ; Zhang ZJ; Wu WZ; Yang YK
    BMC Complement Altern Med; 2013 Jul; 13():185. PubMed ID: 23870199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
    Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
    Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDCD6 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis through the AKT/GSK3β/β-catenin Pathway.
    Wen SY; Liu YT; Wei BY; Ma JQ; Chen YY
    Biomed Environ Sci; 2023 Mar; 36(3):241-252. PubMed ID: 37005078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevoflurane Inhibits Metastasis in Hepatocellular Carcinoma by Inhibiting MiR-665-Induced Activation of the ERK/MMP Pathway.
    Zhu X; Peng C; Peng Z; Chang R; Guo Q
    Cell Transplant; 2022; 31():9636897221104447. PubMed ID: 35699095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
    Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
    Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z
    Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
    Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
    Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.